efficacy of semaglutide tirzepatide versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial | Diabetologia We are all anxiously awaiting

A 2023 study published in JAMA Ophthalmology examined over 16,000 patients and found a small but statistically significant increased risk of certain retinal complications in those prescribed semaglutide compared to other diabetes medications

Increased leptin also causes an increase in metabolic rate

Possibly, but usually mild

[1] The proposal targets the 503B bulks list one of the legal pathways that has allowed large-scale compounding of GLP-1 medications to flow into the telehealth market over the past several years

Many adults struggle with insulin resistance, weight regain, and declining metabolic flexibility